Edaravone
Orphan DrugFDA Approved
Contents
Description
Edaravone is a free radical scavenger used to slow the decline in function in amyotrophic lateral sclerosis (ALS). It is administered intravenously.
Indications & Therapeutic Use
Amyotrophic Lateral Sclerosis (ALS)
Global Availability (2 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — |
Buy / Source Edaravone — GNH India
24 matching products available through GNH India. Select a product to view details and request a quote on the GNH India website.
Edaravone
30 mg/100mLinjectionUSA
Nuravon
1.5mg/ml*20mlampoulesIndia
Parkinson
1.5mg/ml x 20ml
Radicava
30mg/100mlbottlesSwitzerland
Radicava ors
105mg/5mlsuspensionSwitzerland
Radicut
30mg/20mlampoulesJapan
Radicut 30mg/20ml-MIT
30mg/20mlinjectionJapan
Radicut Bag
30mg/100mlvialsJapan
Products and ordering are fulfilled by GNH India. You will be redirected to www.gnhindia.com.
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
Edaravone
| Generic Name | Edaravone |
| Brands | 1 brand available |
| Active Ingredient | Edaravone |
| Drug Class | Amyotrophic Lateral Sclerosis (ALS) |
| Manufacturer | Mitsubishi Tanabe Pharma |
| Dosage Forms | IV infusion |
| Medical Code | M01AX22 |
| Orphan Status | Yes — Orphan Drug |
| Cold Chain | Not Required |
| Lead Time | 7 days |
| Reg. Status | FDA Approved |
| Clinical Trial | NCT02231353 |
| Countries | 2 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations3 Validated Nodes